Monish Aron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Monish Aron has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Narmada P. Gupta
All India Institute of Medical Sciences
12 shared publicationsRajiv Goel
All India Institute of Medical Sciences
12 shared publicationsAmlesh Seth
All India Institute of Medical Sciences
5 shared publicationsGagan Gautam
All India Institute of Medical Sciences
4 shared publicationsPankaj Wadhwa
Department of Urology, All India Institute of Medical Sciences, 110029, New Delhi, India
4 shared publicationsPawan K. Kesarwani
Department of Urology, All India Institute of Medical Sciences, New Delhi, India
4 shared publications
Latest Publications
- 1 May 2017
- Published by Elsevier in European Urology
- Vol. 71 (5) , 727-728
Upholding Rigorous Standards: Comparable Patterns and Rates of Recurrence Between Open and Robot-assisted Radical Cystectomy
- 1 May 2017
- Published by Elsevier in European Urology
- Vol. 71 (5) , 727-728
Upholding Rigorous Standards: Comparable Patterns and Rates of Recurrence Between Open and Robot-assisted Radical Cystectomy
- 1 April 2017
- Published by Springer Nature
- p. 59-72
Laparoscopic Right Donor Nephrectomy (Transperitoneal Approach)
- 1 April 2017
- Published by Springer Nature
- p. 59-72
Laparoscopic Right Donor Nephrectomy (Transperitoneal Approach)
- 30 November 2016
- Published by Springer Nature
- p. 665-681
Practical Solutions for Challenging Robotic Prostatectomy Cases
- 30 November 2016
- Published by Springer Nature
- p. 665-681
Practical Solutions for Challenging Robotic Prostatectomy Cases
- Open Access
- 1 January 2016
- Published by Medknow in Indian Journal of Urology
- Vol. 32 (3) , 238-41
Feasibility of robotic radical prostatectomy for medication refractory chronic prostatitis/chronic pelvic pain syndrome: Initial results
Four patients diagnosed with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), met criteria for National Institute of Health (NIH) Category III prostatitis, failed multiple medicinal treatments and underwent robotic radical prostatectomy (RRP). Median operative time (range): 157 (127–259) min. Validated functional questionnaires responses and NIH CP symptom index (NIH-CPSI) score were collected for each patient's status at different time points pre- and post-operatively. Median decreases (range) were: International Prostate Symptom Score - 14 (1–19); Sexual Health Inventory for Men - 6 (−14–22); and NIH-CPSI total - 23.5 (13–33). Median length of follow-up (range) was 34 (24–43) months. RRP appears to be an option for carefully selected patients with medication-refractory CP/CPPS who understand that baseline sexual function may not be restored postoperatively.
- 1 January 2016
- Published by Medknow in Indian Journal of Urology
- Vol. 32 (3) , 238-41
Open AccessFeasibility of robotic radical prostatectomy for medication refractory chronic prostatitis/chronic pelvic pain syndrome: Initial results
Four patients diagnosed with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), met criteria for National Institute of Health (NIH) Category III prostatitis, failed multiple medicinal treatments and underwent robotic radical prostatectomy (RRP). Median operative time (range): 157 (127–259) min. Validated functional questionnaires responses and NIH CP symptom index (NIH-CPSI) score were collected for each patient's status at different time points pre- and post-operatively. Median decreases (range) were: International Prostate Symptom Score - 14 (1–19); Sexual Health Inventory for Men - 6 (−14–22); and NIH-CPSI total - 23.5 (13–33). Median length of follow-up (range) was 34 (24–43) months. RRP appears to be an option for carefully selected patients with medication-refractory CP/CPPS who understand that baseline sexual function may not be restored postoperatively.
- Open Access
- 1 January 2016
- Published by Medknow in Indian Journal of Urology
- Vol. 32 (2) , 109-14
Extended lymph node dissection in robotic radical prostatectomy: Current status
The role and extent of extended pelvic lymph node dissection (ePLND) during radical prostatectomy (RP) for prostate cancer patients remains unclear. A PubMed literature search was performed for studies reporting on treatment regimens and outcomes in patients with prostate cancer treated by RP and extended lymph node dissection between 1999 and 2013. Studies have shown that RP can improve progression-free and overall survival in patients with lymph node-positive prostate cancer. While this finding requires further validation, it does allow urologists to question the former treatment paradigm of aborting surgery when lymph node invasion from prostate cancer occurred, especially in patients with limited lymph node tumor infiltration. Studies show that intermediate- and high-risk patients should undergo ePLND up to the common iliac arteries in order to improve nodal staging. Evidence from the literature suggests that RP with ePLND improves survival in lymph node-positive prostate cancer. While studies have shown promising results, further improvements and understanding of the surgical technique and post-operative treatment are required to improve treatment for prostate cancer patients with lymph node involvement.
- 1 January 2016
- Published by Medknow in Indian Journal of Urology
- Vol. 32 (2) , 109-14
Open AccessExtended lymph node dissection in robotic radical prostatectomy: Current status
The role and extent of extended pelvic lymph node dissection (ePLND) during radical prostatectomy (RP) for prostate cancer patients remains unclear. A PubMed literature search was performed for studies reporting on treatment regimens and outcomes in patients with prostate cancer treated by RP and extended lymph node dissection between 1999 and 2013. Studies have shown that RP can improve progression-free and overall survival in patients with lymph node-positive prostate cancer. While this finding requires further validation, it does allow urologists to question the former treatment paradigm of aborting surgery when lymph node invasion from prostate cancer occurred, especially in patients with limited lymph node tumor infiltration. Studies show that intermediate- and high-risk patients should undergo ePLND up to the common iliac arteries in order to improve nodal staging. Evidence from the literature suggests that RP with ePLND improves survival in lymph node-positive prostate cancer. While studies have shown promising results, further improvements and understanding of the surgical technique and post-operative treatment are required to improve treatment for prostate cancer patients with lymph node involvement.
- 1 August 2014
- Published by Elsevier in European Urology
- Vol. 66 (2) , 321-329
Transvesical Robotic Simple Prostatectomy: Initial Clinical Experience
- 1 August 2014
- Published by Elsevier in European Urology
- Vol. 66 (2) , 321-329
Transvesical Robotic Simple Prostatectomy: Initial Clinical Experience
- 14 February 2014
- Published by Wiley in BJU International
- Vol. 113 (3) , 354-355
Mid‐term UK outcomes data after extraperitoneal laparoscopic radical prostatectomy
- 14 February 2014
- Published by Wiley in BJU International
- Vol. 113 (3) , 354-355
Mid‐term UK outcomes data after extraperitoneal laparoscopic radical prostatectomy
- Open Access
- 1 January 2014
- Published by Medknow in Indian Journal of Urology
- Vol. 30 (3) , 275-282
Robotic nephron-sparing surgery for renal tumors: Current status
There have been a number of advances in robotic partial nephrectomy (RPN) for renal masses. We reviewed these advances with emphasis on the evolution of technique and outcomes as well as the expanding indications for RPN. Literature in the English language was reviewed using the National Library of Medicine database. Relevant articles were extracted, and their citations were utilized to broaden our search. The identified articles were reviewed and summarized with a focus on novel developments. RPN is an evolving procedure and is an emerging viable alternative to laparoscopic partial nephrectomy and open partial nephrectomy with favorable outcomes. The contemporary techniques used for RPN demonstrate excellent perioperative outcomes. The short-term oncologic outcomes are comparable to those of laparoscopic and open surgical approaches. Further studies are needed to assess long-term oncologic control.
- 1 January 2014
- Published by Medknow in Indian Journal of Urology
- Vol. 30 (3) , 275-282
Open AccessRobotic nephron-sparing surgery for renal tumors: Current status
There have been a number of advances in robotic partial nephrectomy (RPN) for renal masses. We reviewed these advances with emphasis on the evolution of technique and outcomes as well as the expanding indications for RPN. Literature in the English language was reviewed using the National Library of Medicine database. Relevant articles were extracted, and their citations were utilized to broaden our search. The identified articles were reviewed and summarized with a focus on novel developments. RPN is an evolving procedure and is an emerging viable alternative to laparoscopic partial nephrectomy and open partial nephrectomy with favorable outcomes. The contemporary techniques used for RPN demonstrate excellent perioperative outcomes. The short-term oncologic outcomes are comparable to those of laparoscopic and open surgical approaches. Further studies are needed to assess long-term oncologic control.
- Open Access
- 1 January 2014
- Published by Medknow in Indian Journal of Urology
- Vol. 30 (3) , 273-4
Robotic surgery beyond the prostate
Indian J Urol, Official publications of Urological Society of India.
- 1 January 2014
- Published by Medknow in Indian Journal of Urology
- Vol. 30 (3) , 273-4
Open AccessRobotic surgery beyond the prostate
Indian J Urol, Official publications of Urological Society of India.
- 18 August 2012
- Published by Springer Nature
- p. 293-300
LESS: Pelvic Reconstructive Urological Surgery